Ratings changes for Prothena, NVIDIA, Novavax, LightPath Technologies, Jazz Pharmaceuticals, ODDITY Tech, Southern Missouri Bancorp and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point.
In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.
The Coin That Could Define Trump’s Crypto Presidency (ad)
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
COO Javier Olivan sold 517 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $755.11, for a total value of $390,391.87. Following the completion of the transaction, the chief operating officer owned 12,611 shares in the company, valued at $9,522,692.21. This represents a 3.94% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
International Paper (NYSE:IP) was upgraded by analysts at Bank of America Corporation from a “neutral” rating to a “buy” rating. They now have a $57.00 price target on the stock, up previously from $55.00. This represents a 15.4% upside from the current price of $49.40.
Rambus (NASDAQ:RMBS) was upgraded by analysts at Arete from a “neutral” rating to a “buy” rating. They now have a $91.00 price target on the stock. This represents a 16.6% upside from the current price of $78.03.
Silgan (NYSE:SLGN) was upgraded by analysts at Bank of America Corporation from a “neutral” rating to a “buy” rating. They now have a $57.00 price target on the stock. This represents a 21.3% upside from the current price of $47.01.
Venture Global (NYSE:VG) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating. They now have a $17.00 price target on the stock. This represents a 28.6% upside from the current price of $13.22.
Fractyl Health (NASDAQ:GUTS) is now covered by analysts at LADENBURG THALM/SH SH. They set a “buy” rating and a $3.60 price target on the stock. This represents a 260.7% upside from the current price of $1.00.
Northpointe Bancshares (NYSE:NPB) is now covered by analysts at Janney Montgomery Scott. They set a “neutral” rating and a $19.25 price target on the stock. This represents a 8.5% upside from the current price of $17.75.
Novavax (NASDAQ:NVAX) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $10.00 price target on the stock. This represents a 33.0% upside from the current price of $7.52.
ODDITY Tech (NASDAQ:ODD) is now covered by analysts at Needham & Company LLC. They set a “buy” rating and a $72.00 price target on the stock. This represents a 18.0% upside from the current price of $61.04.
P3 Health Partners (NASDAQ:PIII) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $20.00 price target on the stock. This represents a 201.9% upside from the current price of $6.63.
Southern Missouri Bancorp (NASDAQ:SMBC) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $66.00 price target on the stock. This represents a 16.8% upside from the current price of $56.51.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.